お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は循環する腫瘍細胞と癌幹細胞市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは循環する腫瘍細胞と癌幹細胞の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の循環する腫瘍細胞と癌幹細胞市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは循環する腫瘍細胞と癌幹細胞のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に循環する腫瘍細胞と癌幹細胞市場を分類しています。本研究に含まれる主な企業は：QIAGEN Hannover、AVIVA Biosciences、Epic Sciences、ApoCell、Cynvenio Biosystems、Fluxion Biosciences、Rarecells、Janssen Diagnostics、CellTraffix、Silicon Biosystems、Advanced Cell Diagnostics

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Cell Enrichment
    Cell Detection
    CTC Analysis

用途別の市場セグメント：
    Hospital
    NSC
    Medical Research Institute

本レポートの詳細内容
世界の循環する腫瘍細胞と癌幹細胞市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、循環する腫瘍細胞と癌幹細胞タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の循環する腫瘍細胞と癌幹細胞収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の循環する腫瘍細胞と癌幹細胞市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、循環する腫瘍細胞と癌幹細胞市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

循環する腫瘍細胞と癌幹細胞のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：循環する腫瘍細胞と癌幹細胞のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：循環する腫瘍細胞と癌幹細胞の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章循環する腫瘍細胞と癌幹細胞企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：循環する腫瘍細胞と癌幹細胞の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：循環する腫瘍細胞と癌幹細胞の主要企業の概要を提供し、製品の説明と仕様、循環する腫瘍細胞と癌幹細胞の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Circulating tumor cells (CTCs) are tumor cells that detach from the primary tumor and travel in the bloodstream, spreading from the original tumor to other locations, leading to cancer metastasis. These cells exist in peripheral blood of cancer patients and detection of CTCs can help to determine the process of metastasis. In contrast with other blood cells, the number of CTCs is very rare in blood which makes them difficult to detect.
Cancer stem cells (CSCs) are cancer cells that have all the classical properties of normal stem cells. Specifically, they are able to both give rise to more copies of themselves and to give rise to all cell types found in the cancer.
Market Analysis and Insights: Global Circulating Tumor Cells and Cancer Stem Cells Market
The global Circulating Tumor Cells and Cancer Stem Cells market is projected to grow from US$ 16860 million in 2024 to US$ 39000 million by 2030, at a Compound Annual Growth Rate (CAGR) of 15.0% during the forecast period.
The major players in global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market include Janssen, Qiagen, Advanced Cell Diagnostics, etc. North America and Europe are main markets, they occupy about 65% of the global market. CellSearch is the main type, with a share about 70%. Breast Cancer Diagnosis and Treatment, Colorectal Cancer Diagnosis and Treatment are main applications, which hold a share about 60%.
Report Covers:
This report presents an overview of global market for Circulating Tumor Cells and Cancer Stem Cells market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Circulating Tumor Cells and Cancer Stem Cells, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Circulating Tumor Cells and Cancer Stem Cells, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Circulating Tumor Cells and Cancer Stem Cells revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Circulating Tumor Cells and Cancer Stem Cells market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Circulating Tumor Cells and Cancer Stem Cells revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including QIAGEN Hannover, AVIVA Biosciences, Epic Sciences, ApoCell, Cynvenio Biosystems, Fluxion Biosciences, Rarecells, Janssen Diagnostics and CellTraffix, etc.

Market Segmentation
By Company
    QIAGEN Hannover
    AVIVA Biosciences
    Epic Sciences
    ApoCell
    Cynvenio Biosystems
    Fluxion Biosciences
    Rarecells
    Janssen Diagnostics
    CellTraffix
    Silicon Biosystems
    Advanced Cell Diagnostics

Segment by Type
    Cell Enrichment
    Cell Detection
    CTC Analysis

Segment by Application
    Hospital
    NSC
    Medical Research Institute

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Circulating Tumor Cells and Cancer Stem Cells in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Circulating Tumor Cells and Cancer Stem Cells companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Circulating Tumor Cells and Cancer Stem Cells revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Circulating Tumor Cells and Cancer Stem Cells Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Cell Enrichment
    Table 3. Key Players of Cell Detection
    Table 4. Key Players of CTC Analysis
    Table 5. Global Circulating Tumor Cells and Cancer Stem Cells Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Circulating Tumor Cells and Cancer Stem Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Circulating Tumor Cells and Cancer Stem Cells Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Region (2019-2024)
    Table 9. Global Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Region (2025-2030)
    Table 11. Circulating Tumor Cells and Cancer Stem Cells Market Trends
    Table 12. Circulating Tumor Cells and Cancer Stem Cells Market Drivers
    Table 13. Circulating Tumor Cells and Cancer Stem Cells Market Challenges
    Table 14. Circulating Tumor Cells and Cancer Stem Cells Market Restraints
    Table 15. Global Circulating Tumor Cells and Cancer Stem Cells Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Circulating Tumor Cells and Cancer Stem Cells Revenue Share by Players (2019-2024)
    Table 17. Global Top Circulating Tumor Cells and Cancer Stem Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells and Cancer Stem Cells as of 2023)
    Table 18. Global Circulating Tumor Cells and Cancer Stem Cells Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Circulating Tumor Cells and Cancer Stem Cells Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Circulating Tumor Cells and Cancer Stem Cells, Headquarters and Area Served
    Table 21. Global Key Players of Circulating Tumor Cells and Cancer Stem Cells, Product and Application
    Table 22. Global Key Players of Circulating Tumor Cells and Cancer Stem Cells, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Circulating Tumor Cells and Cancer Stem Cells Revenue Market Share by Type (2019-2024)
    Table 26. Global Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Circulating Tumor Cells and Cancer Stem Cells Revenue Market Share by Type (2025-2030)
    Table 28. Global Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Circulating Tumor Cells and Cancer Stem Cells Revenue Share by Application (2019-2024)
    Table 30. Global Circulating Tumor Cells and Cancer Stem Cells Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Circulating Tumor Cells and Cancer Stem Cells Revenue Share by Application (2025-2030)
    Table 32. North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Circulating Tumor Cells and Cancer Stem Cells Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Circulating Tumor Cells and Cancer Stem Cells Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Circulating Tumor Cells and Cancer Stem Cells Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Circulating Tumor Cells and Cancer Stem Cells Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Circulating Tumor Cells and Cancer Stem Cells Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Circulating Tumor Cells and Cancer Stem Cells Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size by Country (2025-2030) & (US$ Million)
    Table 64. QIAGEN Hannover Company Details
    Table 65. QIAGEN Hannover Business Overview
    Table 66. QIAGEN Hannover Circulating Tumor Cells and Cancer Stem Cells Product
    Table 67. QIAGEN Hannover Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024) & (US$ Million)
    Table 68. QIAGEN Hannover Recent Developments
    Table 69. AVIVA Biosciences Company Details
    Table 70. AVIVA Biosciences Business Overview
    Table 71. AVIVA Biosciences Circulating Tumor Cells and Cancer Stem Cells Product
    Table 72. AVIVA Biosciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024) & (US$ Million)
    Table 73. AVIVA Biosciences Recent Developments
    Table 74. Epic Sciences Company Details
    Table 75. Epic Sciences Business Overview
    Table 76. Epic Sciences Circulating Tumor Cells and Cancer Stem Cells Product
    Table 77. Epic Sciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024) & (US$ Million)
    Table 78. Epic Sciences Recent Developments
    Table 79. ApoCell Company Details
    Table 80. ApoCell Business Overview
    Table 81. ApoCell Circulating Tumor Cells and Cancer Stem Cells Product
    Table 82. ApoCell Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024) & (US$ Million)
    Table 83. ApoCell Recent Developments
    Table 84. Cynvenio Biosystems Company Details
    Table 85. Cynvenio Biosystems Business Overview
    Table 86. Cynvenio Biosystems Circulating Tumor Cells and Cancer Stem Cells Product
    Table 87. Cynvenio Biosystems Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024) & (US$ Million)
    Table 88. Cynvenio Biosystems Recent Developments
    Table 89. Fluxion Biosciences Company Details
    Table 90. Fluxion Biosciences Business Overview
    Table 91. Fluxion Biosciences Circulating Tumor Cells and Cancer Stem Cells Product
    Table 92. Fluxion Biosciences Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024) & (US$ Million)
    Table 93. Fluxion Biosciences Recent Developments
    Table 94. Rarecells Company Details
    Table 95. Rarecells Business Overview
    Table 96. Rarecells Circulating Tumor Cells and Cancer Stem Cells Product
    Table 97. Rarecells Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024) & (US$ Million)
    Table 98. Rarecells Recent Developments
    Table 99. Janssen Diagnostics Company Details
    Table 100. Janssen Diagnostics Business Overview
    Table 101. Janssen Diagnostics Circulating Tumor Cells and Cancer Stem Cells Product
    Table 102. Janssen Diagnostics Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024) & (US$ Million)
    Table 103. Janssen Diagnostics Recent Developments
    Table 104. CellTraffix Company Details
    Table 105. CellTraffix Business Overview
    Table 106. CellTraffix Circulating Tumor Cells and Cancer Stem Cells Product
    Table 107. CellTraffix Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024) & (US$ Million)
    Table 108. CellTraffix Recent Developments
    Table 109. Silicon Biosystems Company Details
    Table 110. Silicon Biosystems Business Overview
    Table 111. Silicon Biosystems Circulating Tumor Cells and Cancer Stem Cells Product
    Table 112. Silicon Biosystems Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024) & (US$ Million)
    Table 113. Silicon Biosystems Recent Developments
    Table 114. Advanced Cell Diagnostics Company Details
    Table 115. Advanced Cell Diagnostics Business Overview
    Table 116. Advanced Cell Diagnostics Circulating Tumor Cells and Cancer Stem Cells Product
    Table 117. Advanced Cell Diagnostics Revenue in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024) & (US$ Million)
    Table 118. Advanced Cell Diagnostics Recent Developments
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Circulating Tumor Cells and Cancer Stem Cells Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Type: 2023 VS 2030
    Figure 3. Cell Enrichment Features
    Figure 4. Cell Detection Features
    Figure 5. CTC Analysis Features
    Figure 6. Global Circulating Tumor Cells and Cancer Stem Cells Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Application: 2023 VS 2030
    Figure 8. Hospital Case Studies
    Figure 9. NSC Case Studies
    Figure 10. Medical Research Institute Case Studies
    Figure 11. Circulating Tumor Cells and Cancer Stem Cells Report Years Considered
    Figure 12. Global Circulating Tumor Cells and Cancer Stem Cells Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Circulating Tumor Cells and Cancer Stem Cells Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Region: 2023 VS 2030
    Figure 15. Global Circulating Tumor Cells and Cancer Stem Cells Market Share by Players in 2023
    Figure 16. Global Top Circulating Tumor Cells and Cancer Stem Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Circulating Tumor Cells and Cancer Stem Cells as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Circulating Tumor Cells and Cancer Stem Cells Revenue in 2023
    Figure 18. North America Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Circulating Tumor Cells and Cancer Stem Cells Market Share by Type (2019-2030)
    Figure 20. North America Circulating Tumor Cells and Cancer Stem Cells Market Share by Application (2019-2030)
    Figure 21. North America Circulating Tumor Cells and Cancer Stem Cells Market Share by Country (2019-2030)
    Figure 22. United States Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Circulating Tumor Cells and Cancer Stem Cells Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Circulating Tumor Cells and Cancer Stem Cells Market Share by Type (2019-2030)
    Figure 26. Europe Circulating Tumor Cells and Cancer Stem Cells Market Share by Application (2019-2030)
    Figure 27. Europe Circulating Tumor Cells and Cancer Stem Cells Market Share by Country (2019-2030)
    Figure 28. Germany Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Circulating Tumor Cells and Cancer Stem Cells Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Circulating Tumor Cells and Cancer Stem Cells Market Share by Type (2019-2030)
    Figure 36. China Circulating Tumor Cells and Cancer Stem Cells Market Share by Application (2019-2030)
    Figure 37. Asia Circulating Tumor Cells and Cancer Stem Cells Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Circulating Tumor Cells and Cancer Stem Cells Market Share by Type (2019-2030)
    Figure 39. Asia Circulating Tumor Cells and Cancer Stem Cells Market Share by Application (2019-2030)
    Figure 40. Asia Circulating Tumor Cells and Cancer Stem Cells Market Share by Region (2019-2030)
    Figure 41. Japan Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Circulating Tumor Cells and Cancer Stem Cells Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Circulating Tumor Cells and Cancer Stem Cells Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Circulating Tumor Cells and Cancer Stem Cells Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Circulating Tumor Cells and Cancer Stem Cells Market Share by Country (2019-2030)
    Figure 51. Brazil Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Circulating Tumor Cells and Cancer Stem Cells Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. QIAGEN Hannover Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024)
    Figure 58. AVIVA Biosciences Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024)
    Figure 59. Epic Sciences Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024)
    Figure 60. ApoCell Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024)
    Figure 61. Cynvenio Biosystems Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024)
    Figure 62. Fluxion Biosciences Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024)
    Figure 63. Rarecells Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024)
    Figure 64. Janssen Diagnostics Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024)
    Figure 65. CellTraffix Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024)
    Figure 66. Silicon Biosystems Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024)
    Figure 67. Advanced Cell Diagnostics Revenue Growth Rate in Circulating Tumor Cells and Cancer Stem Cells Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed